Recurrent Mediastinal Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent Mediastinal Lymphoma
| Record | Firm | Date |
|---|---|---|
| Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma (NCT02568553) | National Cancer Institute (NCI) | 2016-11-15 |
Track Recurrent Mediastinal Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.